Large-Scale Metabolomic Profiling for the Diagnosis of Inborn Errors of Metabolism

Key facts

Sponsor

Mayo Clinic

Principal Investigator

David Deyle, MD

Mayo Clinic

Enrollment

240 enrolled

Eligibility

All sexes

Timeline

2019 – 2025

Study locations (1)

• Mayo Clinic in Rochester, Rochester, Minnesota, United States

Collaborators

National Institute of Neurological Disorders and Stroke (NINDS)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Disorder of multiple glycosylation

Additional recruiting or active studies for the same condition.

• RECRUITINGNCT04199000
  Clinical and Basic Investigations Into Congenital Disorders of Glycosylation
  Icahn School of Medicine at Mount Sinai
• RECRUITINGNCT02089789
  Clinical and Basic Investigations Into Known and Suspected Congenital Disorders of Glycosylation
  National Human Genome Research Institute (NHGRI)

See all trials for Disorder of multiple glycosylation →